ConductScience.org, home
Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma
API referenceFor AI assistants

Trial · NCT00513604

Results by group40

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 40

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
Clinical ResponseCohort 1 - NMA, TIL, AldesleukinComplete Response1Participants
Clinical ResponseCohort 2 - NMA, CD4+ TIL, AldesleukinComplete Response3Participants
Clinical ResponseCohort 3 - NMA, Total Body IrradiationComplete Response3Participants
Clinical ResponseCohort 4 - NMA, Young TIL, AldesleukinComplete Response2Participants
Clinical ResponseCohort 5 - NMA, CD4+TIL, HD AldesleukinComplete Response3Participants
Clinical ResponseCohort 1 - NMA, TIL, AldesleukinPartial Response3Participants
Clinical ResponseCohort 2 - NMA, CD4+ TIL, AldesleukinPartial Response18Participants
Clinical ResponseCohort 3 - NMA, Total Body IrradiationPartial Response7Participants
Clinical ResponseCohort 4 - NMA, Young TIL, AldesleukinPartial Response10Participants
Clinical ResponseCohort 5 - NMA, CD4+TIL, HD AldesleukinPartial Response4Participants
Clinical ResponseCohort 1 - NMA, TIL, AldesleukinProgression20Participants
Clinical ResponseCohort 2 - NMA, CD4+ TIL, AldesleukinProgression16Participants
Clinical ResponseCohort 3 - NMA, Total Body IrradiationProgression12Participants
Clinical ResponseCohort 4 - NMA, Young TIL, AldesleukinProgression21Participants
Clinical ResponseCohort 5 - NMA, CD4+TIL, HD AldesleukinProgression24Participants
Clinical ResponseCohort 1 - NMA, TIL, AldesleukinStable Disease0Participants
Clinical ResponseCohort 2 - NMA, CD4+ TIL, AldesleukinStable Disease0Participants
Clinical ResponseCohort 3 - NMA, Total Body IrradiationStable Disease0Participants
Clinical ResponseCohort 4 - NMA, Young TIL, AldesleukinStable Disease1Participants
Clinical ResponseCohort 5 - NMA, CD4+TIL, HD AldesleukinStable Disease4Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00513604/results

API referenceFor AI assistants